
### [MONDO:0015759](http://purl.obolibrary.org/obo/MONDO_0015759)
**Label:** b-cell non-Hodgkin lymphoma

**Subclasses:** [MONDO:0015819](http://purl.obolibrary.org/obo/MONDO_0015819) (indolent primary cutaneous b-cell lymphoma), [MONDO:0015818](http://purl.obolibrary.org/obo/MONDO_0015818) (aggressive primary cutaneous b-cell lymphoma), [MONDO:0017595](http://purl.obolibrary.org/obo/MONDO_0017595) (aggressive b-cell non-Hodgkin lymphoma), [MONDO:0007243](http://purl.obolibrary.org/obo/MONDO_0007243) (Burkitts lymphoma), [MONDO:0004948](http://purl.obolibrary.org/obo/MONDO_0004948) (chronic lymphocytic leukemia), [MONDO:0018905](http://purl.obolibrary.org/obo/MONDO_0018905) (diffuse large B-cell lymphoma), [MONDO:0017594](http://purl.obolibrary.org/obo/MONDO_0017594) (indolent b-cell non-Hodgkin lymphoma), [MONDO:0018906](http://purl.obolibrary.org/obo/MONDO_0018906) (follicular lymphoma), [MONDO:0007926](http://purl.obolibrary.org/obo/MONDO_0007926) (Waldenstrom macroglobulinemia), [MONDO:0020511](http://purl.obolibrary.org/obo/MONDO_0020511) (precursor b-cell acute lymphoblastic leukemia), [MONDO:0017604](http://purl.obolibrary.org/obo/MONDO_0017604) (marginal zone lymphoma), 

**Corr. equiv. classes:** [Orphanet:99860](http://www.orpha.net/ORDO/Orphanet_99860), [Orphanet:178557](http://www.orpha.net/ORDO/Orphanet_178557), [Orphanet:300846](http://www.orpha.net/ORDO/Orphanet_300846), [Orphanet:300912](http://www.orpha.net/ORDO/Orphanet_300912), [Orphanet:33226](http://www.orpha.net/ORDO/Orphanet_33226), [Orphanet:300842](http://www.orpha.net/ORDO/Orphanet_300842), [Orphanet:178554](http://www.orpha.net/ORDO/Orphanet_178554), [OMIM:153600](http://purl.obolibrary.org/obo/OMIM_153600), [OMIM:113970](http://purl.obolibrary.org/obo/OMIM_113970), [Orphanet:67038](http://www.orpha.net/ORDO/Orphanet_67038), [Orphanet:544](http://www.orpha.net/ORDO/Orphanet_544), [Orphanet:543](http://www.orpha.net/ORDO/Orphanet_543), [Orphanet:545](http://www.orpha.net/ORDO/Orphanet_545), 

**Class expressions from DL-Learner:**

- [HP:0002665](http://purl.obolibrary.org/obo/HP_0002665) (Lymphoma) and (not ([HP:0011842](http://purl.obolibrary.org/obo/HP_0011842) (Abnormality of skeletal morphology))) 45.54%
- [HP:0002665](http://purl.obolibrary.org/obo/HP_0002665) (Lymphoma) and (not ([HP:0000924](http://purl.obolibrary.org/obo/HP_0000924) (Abnormality of the skeletal system))) 45.54%
- [HP:0002665](http://purl.obolibrary.org/obo/HP_0002665) (Lymphoma) and (not ([HP:0009121](http://purl.obolibrary.org/obo/HP_0009121) (Abnormal axial skeleton morphology))) 41.20%
- [HP:0002665](http://purl.obolibrary.org/obo/HP_0002665) (Lymphoma) and (not ([HP:0000164](http://purl.obolibrary.org/obo/HP_0000164) (Abnormality of the dentition))) 38.33%
- [HP:0002665](http://purl.obolibrary.org/obo/HP_0002665) (Lymphoma) and (not ([HP:0000498](http://purl.obolibrary.org/obo/HP_0000498) (Blepharitis))) 37.75%
- [HP:0002665](http://purl.obolibrary.org/obo/HP_0002665) (Lymphoma) 35.80%
- [HP:0002665](http://purl.obolibrary.org/obo/HP_0002665) (Lymphoma) and (not ([HP:0000013](http://purl.obolibrary.org/obo/HP_0000013) (Hypoplasia of the uterus))) 35.80%
- [HP:0002665](http://purl.obolibrary.org/obo/HP_0002665) (Lymphoma) and (not ([HP:0000012](http://purl.obolibrary.org/obo/HP_0000012) (Urinary urgency))) 35.80%
- [HP:0002665](http://purl.obolibrary.org/obo/HP_0002665) (Lymphoma) and (not ([HP:0000011](http://purl.obolibrary.org/obo/HP_0000011) (Neurogenic bladder))) 35.80%
- [HP:0002665](http://purl.obolibrary.org/obo/HP_0002665) (Lymphoma) and (not ([HP:0000004](http://purl.obolibrary.org/obo/HP_0000004) (null))) 35.80%
- [HP:0002665](http://purl.obolibrary.org/obo/HP_0002665) (Lymphoma) and (not ([HP:0000003](http://purl.obolibrary.org/obo/HP_0000003) (Multicystic kidney dysplasia))) 35.80%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) 29.67%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 26.43%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) 26.12%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 26.07%


